Comment on: determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance
AUTOR(ES)
Simpson, David C.
FONTE
Rev. Bras. Hematol. Hemoter.
DATA DE PUBLICAÇÃO
2013
RESUMO
Documentos Relacionados
- Determination of serum levels of imatinib mesylate in patients with chronic myeloid leukemia: validation and application of a new analytical method to monitor treatment compliance
- Molecular response to imatinib mesylate of Brazilian patients with chronic myeloid leukemia
- Adherence and/or discontinuation of imatinib mesylate in patients with chronic myeloid leukemia
- Scientific comment on: "Analysis of imatinib adherence in chronic myeloid leukemia: a retrospective study in a referral hospital in the Brazilian Amazon". Who likes to take medicine forever?
- Positive response to imatinib mesylate therapy for childhood chronic myeloid leukemia